147
Views
22
CrossRef citations to date
0
Altmetric
Original Articles

Protective Effect of Pistacia lentiscus Oil Against Bleomycin-Induced Lung Fibrosis and Oxidative Stress in Rat

, , , , &
Pages 490-497 | Received 19 Jul 2016, Accepted 09 Dec 2016, Published online: 17 Feb 2017

References

  • Tominaga J, Sakai F, Johkoh T, Noma S, Akira M, et al.: Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: the effect of the integrated clinico-radiological assessment. Eur J Radio 84, 2640–2645, 2015.
  • Boniface S, Gaubert JY, Chetaille B, Fraticelli A, Retornaz F, et al.: Classification 2002 des pneumopathies interstitielles idiopathiques. Rev Méd Interne 25, 891–905, 2004.
  • Cottin V and Cordier JF: Fibrose pulmonaire idiopathique. Rev Prat 56, 1165–1171, 2006.
  • Cottin V and Cordier JF: Fibrose pulmonaire idiopathique. Press Méd 2008.
  • Selman M, King Jr TE, and Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134(2), 136–151, 2001.
  • Boehme SA, Franz-Bacon K, Di Tirro DN, Ly TW, and Bacon KB: MAP3K19 is a novel regulator of TGF-β signaling that impacts bleomycin-induced lung injury and pulmonary fibrosis. PLoS One 4(5), 11, 2016.
  • Della Latta V, Cecchettini A, Del Ry S, and Morales MA: Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res 97, 122–130, 2015.
  • Crestani B, Sylvain MA, and Schneider S: Traitements médicamenteux de la fibrose pulmonaire idiopathique. Pneumol Clin 61, 221–231, 2005.
  • Lynch JP, Huynh RH, Fishbein MC, et al.: Idiopathic pulmonary fibrosis: epidemiology, clinical features, prognosis, and management. Semin Respir Crit Care Med 37, 331–357, 2016.
  • Hong WY, Jian PZ, Meng HZ, and Yuan L: Losartan attenuates bleomycin-induced pulmonary fibrosis in rats. Respiration 73, 236–242, 2006.
  • Cottin V and Cordier JF: Idiopathic pulmonary fibrosis. Press Med 37, 1581–1590, 2008.
  • Leporatti ML and Ghedira K: Comparative analysis of medicinal plants used in traditional medicine in Italy and Tunisia. J Ethnobiol Ethnomed 5, 31, 2009.
  • Trabelsi H, Renaud J, Herchi W, Boukhchina S, Mayer P: Triacylglycerols and aliphatic alcohols from fruits of three Tunisian Pistacia lentiscus populations. J Sci Food Agric 10, 2028–2032, 2015.
  • Mezni F, Shili S, Ben Ali N, Larbi Khouja M, Khaldi A, and Maaroufi A: Evaluation of Pistacia lentiscus seed oil and phenolic compounds for in vitro antiproliferative effects against BHK21 cells. Pharm Biol 54(5), 747–751, 2016.
  • Mezni F, Maaroufi A, Msallem M, Boussaid M, Khouja MA, and Khaldi A: Fatty acid composition, antioxidant and antibacterial activities of Pistacia lentiscus L. fruit oils. J. Med. Plants. Res 6(39), 5266–5271, 2012.
  • Charef M, Yousfi M, Saidi M, and Stocker P: Determination of the fatty acid composition of acorn (Quercus), Pistacia lentiscus seeds growing in Algeria. J Am Oil Chem Soc 85, 921–924, 2008.
  • Mharti FZ, Lyoussi B, and Abdellaoui A: Antibacterial activity of the essential oils of Pistacia lentiscus used in Moroccan folkloric medicine. Nat Prod Commun 6(10), 1505–1506, 2011.
  • Loizou S, Paraschos S, Mitakou S, Chrousos GP, Lekakis I, and Moutsatsou P: Chios mastic gum extract and isolated phytosterol tirucallol exhibit anti-inflammatory activity in human aortic endothelial cells. Exp Biol. Med 234(5), 553–561, 2009.
  • Bozorgi M, Memariani Z, Mobli M, Salehi SM, Shams-Ardekani R, and Rahimi R: Five Pistacia species (P. vera, P. atlantica, P. terebinthus, P. khinjuk, and P. lentiscus): a review of their traditional uses, phytochemistry, and pharmacology. Sci World J 2013, ID 219815.
  • Magkouta S, Stathopoulos GT, Psallidas I, Papapetropoulos A, Kolisis FN, et al.: Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma. Nutr Cancer 61(5), 640–648, 2009.
  • Gardeli C, Vassiliki P, Athanasios M, Kibouris T, and Komaitis M: Essential oil composition of Pistacia lentiscus L. and Myrtus communis L: evaluation of antioxidant capacity of methanolic extracts. Food Chem 107(3), 1120–1130, 2008.
  • Djerrou Z: Anti-hypercholesterolemic effect of Pistacia lentiscus fatty oil in egg yolk-fed rabbits: a comparative study with simvastatin. Chin J Nat Med 12(8), 561–566, 2014.
  • Ashcroft T, Simpson JM, and Timbrell V: Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41, 467–470, 1998.
  • Hubner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, et al.: Standardized quantification of pulmonary fibrosis in histological samples. Biotechnolgy 44(4), 507–517, 2008.
  • Zhao Y and Shah DU: Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 69, 67–78, 2000.
  • Abidi A, Serairi R, Kourda N, et al.: Therapeutic effect of flaxseed oil on experimental pulmonary fibrosis induced by bleomycin in rats. Eur J Infl 14(2), 133–143, 2016.
  • Ohkawa H, Ohshi N, and Yagi K: Assay for lipid peroides in animals' tissues by thiobarbituric acid reaction. Anal Biochem 95, 351–358, 1979.
  • Beyer WF and Fridovich I: Assaying for superoxide dismutase activity: some large consequences of minor changes in conditions. Anal Biochem 161, 559–566, 1987.
  • Aebi H: Catalase in vitro. Methods Enzymol 105, 121–126, 1984.
  • Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193(1), 265–275, 1951.
  • Reinert T, Serodio C, Baldotto DR, Nunes FAP, and Scheliga AAS: Bleomycin-induced lung injury. J Cancer Res 2013; ID 480608.
  • Moeller A, Ask K, Warburton D, Gauldie J, and Kolb M: The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40(3), 362–382, 2008.
  • Gail EMM, Ask K, Sarah EG, Kolb M, and Gauldie J: The transforming growth factor-beta (TGFβ) family and pulmonary fibrosis. Drug Discov Today Dis Mech 3(1), 99–103, 2006.
  • Chen T, Nie H, Gao X, Yang J, Pu J, et al.: Epithelial–mesenchymal transition involved in pulmonary fibrosis induced by multi-walled carbon nanotubes via TGF-beta/Smad signaling pathway. Toxicol Lett 226(2), 150–162, 2014.
  • Chung-Ming C, Hsiu-Chu C, Hsun-Hui H, and Leng-Fang W: Transforming growth factor-β1 upregulation is independent of angiotensin in paraquat-induced lung fibrosis. Toxicology 216, 181–187, 2005.
  • Shi K, Jiang J, Ma T, Xie J, Duan L, et al.: Dexamethasone attenuates bleomycin-induced lung fibrosis in mice through TGF-β, Smad3 and JAK-STAT pathway. Int J Clin Exp Med 7(9), 2645–2650, 2014.
  • Mc Anulty RJ, Campa JS, Cambrey AD, and Laurent GJ: The effect of transforming growth factor β on rates of procollagen synthesis and degradation in vitro. Bioch Biophy (BBA) – Mol Cell Res 1091, 231–235, 1991.
  • Zhao Y and Shah DU: Expression of transforming growth factor-β type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Exper Mol Pathol 69, 67–78, 2000.
  • Khalil N, O'connor RN, Unruch HW, Warren PW, Flanders KC, et al.: Increased production and immunohistochimical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Amer J Resp Mol Biol 5, 155–162, 1991.
  • Mokni M, Hamlaoui S, Kadri S, Limam F, Amri M, et al.: Grape seed and skin extract protects kidney from doxorubicin-induced oxidative injury. Pak J Pharm Sci 29(3), 961–968, 2016.
  • Ezzat SM, El Gaafary M, El Sayed AM, Sabry OM, Ali ZY, et al.: The cardenolide glycoside acovenoside affords protective activity in doxorubicin-induced cardiotoxicity in mice. J Pharmacol Exp Ther 2016, jpet.116, 232652.
  • Yokoyama C, Aoyama T, Ido T, Kakino A, Shiraki T, et al.: Deletion of LOX-1 protects against heart failure induced by doxorubicin. PloS One 11(5), e0154994, 2016. doi:10.1371/journal.pone.0154994
  • Zhu J, Song X, Lin HP, Young DC, Yan S, et al.: Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. J. Natl Cancer Inst 94, 1745–1757, 2002.
  • Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, et al.: Nelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo. Clin Cancer Res 13, 5183–5194, 2007.
  • Crouch E: Pathobiology of pulmonary fibrosis. Am J Physiol 259(4 Pt 1), L159–84, 1990.
  • Maxia A, Sanna C, Frau MA, Piras A, Karchuli MS, and Kasture V: Anti-inflammatory activity of Pistacia lentiscus essential oil: involvement of IL-6 and TNF-alpha. Nat Prod Commun 6(10), 1543–1544, 2011.
  • Moulos P, Papadodima O, Chatziioannou A, Loutrari H, Roussos C, and Kolisis FN: A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival. BMC Med Genom 15(2), 68, 2009.
  • Zhou C, Han W, Zhang P, Cai M, Wei D, and Zhang C: Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutr Res 28(2), 122–130, 2008.
  • Iraz M, Erdogan H, Kotuk M, Yağmurca M, Kilic T, et al.: Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats. Pharmacol Res 53(3), 310–316, 2006.
  • Chilakapati SR, Serasanambati M, Manikonda PK, Chilakapati DR, and Watson RR: Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice. Can J Physiol Pharmacol 92(8), 631–639, 2014.
  • Impellizzeri D, Talero E, Siracusa R, Alcaide A, Cordaro M, et al.: Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice. Br J Nutr 28, 853–865, 2015.
  • Klibet F, Boumendjel A, Khiari M, El Feki A, Abdennour C, and Messarah M: Oxidative stress-related liver dysfunction by sodium arsenite: Alleviation by Pistacia lentiscus oil. Pharm Biol 54(2), 354–363, 2016.
  • Nguemeni C, Delplanque B, Rovère C, Simon-Rousseau N, Gandin C, et al.: Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol Res 61, 226–233, 2010.
  • Rebiger L, Lenzen S, and Mehmeti I: Susceptibility of brown adipocytes to pro-inflammatory cytokine toxicity and reactive oxygen species. Biosci Rep 36, 1–11, 2016.
  • Maditz KH, Benedito VA, Oldaker C, Nanda N, Lateef SS, et al.: Feeding soy protein isolate and n-3 PUFA affects polycystic liver disease progression in a PCK rat model of autosomal polycystic kidney disease. J Pediatr Gastroenterol Nutr 60(4), 467–473, 2015.
  • Wiktorowska-Owczarek A, Berezińska M, and Nowak JZ: PUFAs: structures, metabolism and functions. Adv Clin Exp Med 24(6), 931–941, 2015.
  • Calder PC: Polynsatured fatty acids and inflammation. Biochem Soc Trans 33(2), 423–427, 2005.
  • Chirinos R, Zuloeta G, Pedreschi R, Mignolet E, Larondelle Y, and Campos D: Sacha inchi (Plukenetia volubilis): a seed source of polyunsaturated fatty acids, tocopherols, phytosterols, phenolic compounds and antioxidant capacity. Food Chem 141(3), 1732–1739, 2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.